profit from every $100 of sales.
$0$100
Envoy Medical
$0.03+6.45% today
-49.6% in 1 year
1-year low $0.031-year high $0.07
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Envoy Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Envoy Medical | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Envoy Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- 4.6×
- 63.0×
- –
- 0.4×
- -1,860.3%
- -47.3%
- 0.0%
Profitability
- -310.7%
- -9,881.2%
- -9,875.6%
- -9,960.7%
- -130.0%
- 228.9%
- 239.4%
- -77.5%
- -131.3%
- 5,717.9%
Growth
- −6.1%
- –
- +2.9%
- –
- +17.9%
Financial health
- 1.0×
- 0.08
- 3.0%
- -21.1×
- 2.27
- 2.14
- 0.01
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 9%of 868
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | -0.08 | -0.14 | +42.9% |
| Mar 23, 2026 | -0.29 | -0.24 | −20.8% |
| Nov 10, 2025 | -0.33 | -0.24 | −37.8% |
| Jul 31, 2025 | -0.29 | -0.30 | +4.0% |
News
U.S. East Asian envoy says investors are overpricing Taiwan conflict riskCNBC · Oct 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
34No pass
Benjamin Graham
36No pass
Philip Fisher
29No pass
Peter Lynch
41No pass
Joel Greenblatt
42No pass
Charlie Munger
39No pass
Terry Smith
35No pass
Questions about Envoy Medical
Is Envoy Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Envoy Medical AI analysis
What does Envoy Medical do?
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. It is in Medical - Devices.
Does Envoy Medical pay a dividend?
No. Envoy Medical does not pay a dividend at the moment.
How has Envoy Medical stock done over the past year?
Down 49.6% over the past twelve months, to $0.03. It traded between $0.03 and $0.07 and is 54.3% below its high.
Who are Envoy Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Envoy Medical's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.